Health effects of tobacco: Difference between revisions
[pending revision] | [pending revision] |
Line 152: | Line 152: | ||
=== Organic === |
=== Organic === |
||
⚫ | |||
There are over 19 known [[carcinogens]] in cigarettes.<ref>{{cite web|author=Dr. [[C. Everett Koop]]|title=Smoking and smokeless tobacco|url=http://www.drkoop.com/ency/93/002032.html|accessdate=July 15|accessyear=2006}}</ref> The following are some of the most potent carcinogens: |
|||
[[Image:Benzopyrene diol epoxide chemical structure.png|thumb|200px|Chemical structure of the carcinogen [[benzopyrene]] diol epoxide]] |
|||
[[Image:Benzopyrene DNA adduct 1JDG.png|thumb|right|200px|Benzopyrene, a major mutagen in [[tobacco smoking|tobacco smoke]], in an [[adduct]] to DNA.<ref>Created from [http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=1JDG PDB 1JDG]</ref>]] |
|||
* '''[[Polycyclic aromatic hydrocarbon|Polynuclear aromatic hydrocarbons]]''' are tar components produced by [[pyrolysis]] in smoldering organic matter and emitted into smoke. Many of them are highly carcinogenic and mutagenic, because they are [[Toxication|toxicated]] to [[mutagenic]] [[epoxide]]s, which are [[electrophilic alkylating agent]]s. The first PAH to be identified as a carcinogen in tobacco smoke was '''[[benzopyrene]]''', which been shown to toxicate into a diol epoxide and then permanently attach to nuclear DNA, which may either kill the cell or cause a [[genetic mutation]]. The DNA contains the information on how the cell function; in practice, it contains the recipes for protein synthesis. If the mutation inhibits [[programmed cell death]], the cell can survive to become a [[cancer cell]], a cell that does not function like a normal cell. The carcinogenity is radiomimetic, i.e. similar to that produced by ionizing nuclear radiation. Tobacco manufacturers have experimented with combustionless [[vaporizer]] technology to allow cigarettes to be consumed without the formation of carcinogenic benzopyrenes.<ref>{{cite web | title=DNA interaction with Benzopyrene| work=DNA| url=http://www.mybiology.com/chime/dna_benzopyrene/dna_benzopyrene_text.htm| accessdate=March 5 | accessyear=2005}}</ref> However, such products have not become popular. |
|||
* '''[[Acrolein]]''' is a pyrolysis product that is abundant is cigarette smoke. It gives smoke an acrid smell and an irritating, lachromatory effect and is a major contributor to its carcinogenity. Like PAH metabolites, acrolein is also an electrophilic alkylating agent and permanently binds to the DNA base [[guanine]], by a [[conjugate addition]] followed by cyclization into a [[hemiaminal]]. The acrolein-guanine adduct induces mutations during DNA copying and thus causes cancers in a manner similar to PAHs. However, acrolein is 1000 times more abundant than PAHs in cigarette smoke, and is able to react as is, without metabolic activation. Acrolein has been shown to be a [[mutagen]] and [[carcinogen]] in human cells. The carcinogenity of acrolein has been difficult to study by [[animal experimentation]], because it has such a toxicity that it tends to kill the animals before they develop cancer.<ref name="Feng">{{cite journal | last =Feng | first =Z | coauthors =Hu W, Hu Y, Tang M | title =Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair | journal = [[Proceedings of the National Academy of Sciences]]| volume =103 | issue =42 | pages =15404–9 |month =October | year =2006 | url =http://www.pnas.org/cgi/reprint/0607031103v1 | pmid=17030796 | doi=10.1073/pnas.0607031103}}</ref> Generally, compounds able to react by [[conjugate addition]] as [[electrophile]]s (so-called ''Michael acceptors'' after [[Michael reaction]]) are toxic and carcinogenic, because they can permanently alkylate DNA, similarly to [[mustard gas]] or [[aflatoxin]]. Acrolein is only one of them present in cigarette smoke; for example, [[crotonaldehyde]] has been found in cigarette smoke.<ref name="Kataoka">Kataoka, H. et al. Chromatographia, Volume 44, Numbers 9-10 / May, Pages 491-496, 1997. DOI: 10.1007/BF02466742</ref> Michael acceptors also contribute to the chronic inflammation present in tobacco disease.<ref name="Facchinetti" /> |
|||
* '''[[Nitrosamine]]s''' are a group of carcinogenic compounds found in cigarette smoke but not in uncured tobacco leaves. Nitrosamines form on flue-cured tobacco leaves during the curing process through a [[chemical reaction]] between nicotine and other compounds contained in the uncured leaf and various oxides of nitrogen found in all combustion gases. Switching to [[Indirect fire|indirect-fire]] curing has been shown to reduce nitrosamine levels to less than 0.1 parts per million.<ref>{{cite web|author=Sumner et al|title=Retrofitting Tobacco Curing Barns|url=http://www.tifton.uga.edu/tobacco/retrofitinfo.htm|accessdate=June 9|accessyear=2006}}</ref><ref>{{cite web|author=[[NOVA]]|url=http://www.pbs.org/wgbh/nova/cigarette/history2.html|title=Search for a Safer Cigarette}}</ref> |
|||
⚫ | |||
=== Radioactive{{anchor|Radioactive carcinogens}} === |
=== Radioactive{{anchor|Radioactive carcinogens}} === |
Revision as of 15:55, 6 November 2008
Part of a series on |
Tobacco |
---|
The health effects of tobacco can be significant, depending on the way the tobacco is used (smoked, snuffed or chewed) and the amount. Major health effects of smoking, the most common use of tobacco, include an increased risk in lung cancer and cardiovascular disease. The World Health Organization estimate that tobacco caused 5.4 million deaths in 2004[1] and 100 million deaths over the course of the 20th century[2]. Similarly, the United States Centers for Disease Control and Prevention describes tobacco use as "the single most important preventable risk to human health in developed countries and an important cause of premature death worldwide."[3] Rates of smoking have leveled off or declined in the developed world. Smoking rates in the United States have dropped by half from 1965 to 2006 falling from 42% to 20.8% in adults.[4] In the developing world, tobacco consumption is rising by 3.4% per year.[5]
Eyebrow Rocks!!!!!
Primary risks
Regular smokers are estimated to live to 2.5[6] to 10[7] years fewer than nonsmokers.[6] About one-half of male smokers will die of illness due to smoking.[8]
Tobacco related illnesses kill approximately 438,000 USA citizens per year,[9] about 1,200 per day, making it the leading cause of preventable death in the U.S. The World Health Organization has stated that tobacco is set to kill a billion people this century.[10]
Imagine that cigarettes were harmless—except, once in every 25,000 packs, an occasional innocent-looking one is filled with dynamite instead of tobacco. Not such a bad risk of having your head blown off. But with 250 million packs a day consumed worldwide, we could expect to have more than 10,000 gruesome daily deaths—surely enough to have cigarettes banned everywhere.
— David Myers [11]
The main health risks in tobacco pertain to diseases of the cardiovascular system, in particular smoking being a major risk factor for a myocardial infarction (heart attack), diseases of the respiratory tract such as Chronic Obstructive Pulmonary Disease (COPD) and emphysema, and cancer, particularly lung cancer and cancers of the larynx and mouth. It also increases the risk of developing pancreatic cancer by 75%. Prior to World War I, lung cancer was considered to be a rare disease, which most physicians would never see during their career. With the postwar rise in popularity of cigarette smoking came a virtual epidemic of lung cancer.[12][13]
Currently, among people who have ever smoked any kind of tobacco, almost one in ten will develop lung cancer.[2] One in six men who continue to smoke tobacco will develop lung cancer.[14] This compares to only one case of lung cancer in seventy-five lifelong non-smokers.
Incidence of impotence is approximately 85 percent higher in male smokers compared to non-smokers,[15] and it is a key cause of erectile dysfunction (ED).[16][17] Smoking causes impotence because it promotes arterial narrowing.[18]
A person's increased risk of contracting disease is directly proportional to the length of time that a person continues to smoke as well as the amount smoked. However, if someone stops smoking, then these chances gradually decrease as the damage to their body is repaired.[19]
Diseases linked to smoking tobacco cigarettes include:
- Many forms of cancer, particularly lung cancer,[20] cancer of the kidney,[21] cancer of the larynx and head and neck, breast cancer,[22][23] bladder, esophagus, pancreas,[24] and stomach.[25] There is some evidence suggesting an increased risk of myeloid leukemia, squamous cell sinonasal cancer, liver cancer, cervical cancer, colorectal cancer after an extended latency, childhood cancers and cancers of the gall bladder, adrenal gland and small intestine.
- Cardiovascular disease
- Respiratory ailments
- common cold and bronchitis
- Chronic obstructive pulmonary disease, emphysema and chronic bronchitis in particular
- Birth defects of pregnant smokers' offspring
- Buerger's disease (thromboangiitis obliterans)
- Cataracts that may cause blindness[26]
- Cognitive dysfunction
- Impotence
Cigar and pipe smokers tend to inhale less smoke than cigarette smokers, so their risk of lung cancer is lower but is still several times higher than the risk for nonsmokers.[citation needed] Pipe and cigar smokers are also at risk for cancers of the oral cavity, larynx (voice box), or esophagus, a risk which was widely hypothesized before any link between smoking and cancer was scientifically proved as seen in the news coverage of the tobacco-related cancers of two American presidents; Ulysses S. Grant died in 1885 at age sixty-three after a long and painful public battle with throat cancer which was widely assumed at the time to be the result of his lifelong cigar habit, and Grover Cleveland was diagnosed in 1893 with cancer of the left jaw, which was frequently remarked upon by the press and public as the side where he usually had a cigar clamped. Similarly, cancer of the mouth and jaw is also a risk for chewing tobacco. The benefits of smoking cessation are immediate: blood pressure, heart rate, and temperature return to normal range; heart attack risk decreases; ability to smell and taste is enhanced; circulation improves.
It is generally assumed that the major motivational factor behind smoking is the nicotine it contains. However, the practice of ingesting the smoke from a smoldering leaf generates an enormous number of active chemical compounds, loosely lumped together as 'tar', many of which are biologically reactive and potential health dangers. (Chewing tobacco is also carcinogenic, likely because similar compounds are generated in the practice of curing it; the Nordic snus, which is steam cured and therefore does not generate these compounds, is much less carcinogenic.)[citation needed]
Smoke contains, in significant amounts, a large number of potent carcinogens, such as acrolein and benzopyrene. Carcinogenity is effected by alkylation (permanent attachment of foreign bodies) of nuclear DNA.
Long term exposure to other compounds in the smoke, such as carbon monoxide, cyanide, and other compounds that damage lung and arterial tissue, are believed to be responsible for cardiovascular damage and for loss of elasticity in the alveoli, leading to emphysema and COPD. The carcinogen acrolein and its derivatives also contribute to the chronic inflammation present in COPD.[31]
Cardiovascular disease
Smoking also increases the chance of heart disease. Several ingredients of tobacco lead to the narrowing of blood vessels, increasing the likelihood of a blockage, and thus a heart attack or stroke. According to a study by an international team of researchers, people under 40 are five times more likely to have a heart attack if they smoke.[32]
Oral health
Tooth loss has been shown Winn DM |title=Cigar, pipe, RI |title=Tobacco use and incidence of tooth loss among US male health professionals |journal=J. Dent. Res. |volume=86 |issue=4 |pages=373–7 |year=|org/cgiref> higher in smokers than in non-smokers.<-Bayaty FH, Wahid NA, Bulgiba AM |title=Tooth mortality in smokers and nonsmokers in a selected population in Sana'a, Yemen |journal=J. Periodont. Res. |volume|year=2008 |month=February |pmid=18230101 |doi=10.1111/j.1600-0765.2007.00988.x |url=}}</ref>
Psychological effects
Smokers report a variety of physical and psychological effects from smoking tobacco. Those new to smoking will experience nausea, dizziness, and rapid heart beat. The unpleasant symptoms will eventually vanish over time, with repeated use, as the body builds a tolerance to the chemicals in the cigarettes, such as nicotine.
In many respects, nicotine acts on the nervous system in a similar way to caffeine. Some writings have stated that smoking can also increase mental concentration; one study documents a significantly better IQ on the normed Advanced Raven Progressive Matrices test after smoking.[33] Most smokers say they enjoy smoking, which is part of the reason why many continue to do so even though they are aware of the health risks. Taste, smell, and visual enjoyment are also major contributions to the enjoyment of smoking, in addition to camaraderie with other smokers. Ironically, chronic exposure to tobacco smoke may inhibit one's sense of taste and smell, rendering him or her less able to enjoy these aspects of tobacco smoking.
Most smokers, when denied access to nicotine, exhibit symptoms such as irritability, jitteriness, dry mouth, and rapid heart beat.[34] Longer abstinence may lead to insomnia and even mild depression. The onset of these symptoms is very fast, nicotine's half-life being only 1 hour. Withdrawal symptoms can appear even if the smoker's consumption is very limited or irregular, appearing after only 4-5 cigarettes in most adolescents. An ex-smoker's chemical dependence to nicotine will cease after approximately ten to twenty days, although the brain's number of nicotine receptors is permanently altered,[citation needed] and the psychological dependence may linger for months or even many years. Unlike some recreational drugs and alcohol, nicotine does not measurably alter a smoker's motor skills, cognition, judgement, or language abilities while under the influence of the drug, but nicotine withdrawal symptoms such as irritability and incapacity to concentrate can have an influence on these aspects. Tobacco withdrawal has been shown to cause clinically significant distress.[35]
The majority of these effects are due to nicotine withdrawal,[34] and so smokers who are not addicted to nicotine will not suffer from them.
Some studies suggest that a link exists between smoking and mental illness, citing the high incidence of smoking amongst those suffering from schizophrenia[36] and the possibility that smoking may alleviate some of the symptoms of mental illness,[37] but these have not been conclusive.
Reproduction
This section needs expansion with: Effects on prenatal development. You can help by adding to it. (September 2008) |
Semen
There is increasing evidence that the harmful products of tobacco smoking kill sperm cells.[38][39] Therefore, some governments require manufacturers to put warnings on packets. Smoking tobacco increases intake of cadmium, because the tobacco plant absorbs the metal. Cadmium, being chemically similar to zinc, may replace zinc in the DNA polymerase, which plays a critical role in sperm production. Zinc replaced by cadmium in DNA polymerase can be particularly damaging to the testes.[40]
Miscarriage
A number of studies have shown that tobacco use is a significant factor in miscarriage s among pregnant smokers, and that it contributes to a number of other threats to the health of the fetus.[41] Second-hand smoke appears to present an equal danger to the fetus, as one study noted that "heavy paternal smoking increased the risk of early pregnancy loss."[42] Miscarriages are not included in WHO estimates of deaths attributable to smoking.
Sudden Infant Death Syndrome
Secondhand smoke is connected to Sudden Infant Death Syndrome (SIDS). Infants who die from Sudden Infant Death Syndrome tend to have higher concentrations of nicotine and cotinine (a biological marker for secondhand smoke exposure) in their lungs than those who die from other causes. While smoking during pregnancy increases the risk of Sudden Infant Death Syndrome, infants exposed to secondhand smoke after birth are also at a greater risk of Sudden Infant Death Syndrome whether or not the parent(s) smoked during pregnancy. The nicotine obtained from smoking travels through a woman into her breast milk, thus giving nicotine to her child.[43]
Erectile Dysfunction
Smoking is linked to erectile dysfunction, also known as male impotence. The incidence of this is approximately 85% higher in male smokers compared to non-smokers.[44]
Infectious Diseases
Tobacco is also linked to susceptibility to infectious diseases, particularly in the lungs. Smoking more than 20 cigarettes a day increases the risk of tuberculosis by two to four times[45][46], and being a current smoker has been linked to a four-fold increase in the risk of invasive pneumococcal disease[47]. It is believed that smoking increases the risk of these and other pulmonary and respiratory tract infections both through structural damage and through effects on the immune system. The effects on the immune system include an increase in CD4+ cell production attributable to nicotine, which has tentatively been linked to increased HIV susceptibility[48].
Risks type
Low tar/light cigarettes
There is no credible evidence that "Low Tar," "Light," or "Ultra Light" cigarettes are safer than regular cigarettes.[49]
Most of these terms refer to the type of filter that is used, and can vary depending on the brand. In some countries, advertising cigarettes as being "Light" has been banned.
Cigar vs cigarette smoking
Although cigarette smoking causes a greater increase of the risk of cancer than cigar smoking, cigar smokers still have an increased risk for many health problems, including cancer, when compared to non-smokers.[50][51] The National Institutes of Health, through the National Cancer Institute, determined in 1998 that "cigar smoking causes a variety of cancers including cancers of the oral cavity (lip, tongue, mouth, throat), esophagus, larynx, and lung."[52] Relative risk for cigar-only smokers of all-cause mortality is 1.02 for 1-2 cigars/day, 1.08 for 3-4 cigars/day, and 1.17 for 5+ cigars/day. The NIH study concerned those who smoked at least one cigar per day, and stated "The health risks associated with less than daily smoking (occasional smokers) are not known."[52] Though most cigar smokers do not inhale, those that do have risks of lung cancer similar to cigarette smokers. Increased risk for heart attack is less for cigar smokers, but still present. As for Environmental Tobacco Smoke (ETS, or "Second-hand Smoking"), the NIH study points to the large amount of smoke generated by one cigar, saying "cigars can contribute substantial amounts of tobacco smoke to the indoor environment; and, when large numbers of cigar smokers congregate together in a cigar smoking event, the amount of ETS produced is sufficient to be a health concern for those regularly required to work in those environments."[52]
Pipe smoking
Pipe smoking involves significant health risks,[53][54][55] particularly oral cancer.[56][57] A 1979 United States Surgeon General report on smoking indicated that exclusive pipe smokers smoking less than five pipe bowls a day had a lower mortality rate than non-smokers [58]. The report also indicated a higher mortality rates for pipe smokers smoking more than four pipe bowls per day compared to non-smokers, but still below that of cigarette and cigar smokers.
Secondhand smoke
Secondhand smoke is a mixture of smoke from the burning end of a cigarette, pipe or cigar and the smoke exhaled from the lungs of smokers. It is involuntarily inhaled, lingers in the air hours after cigarettes have been extinguished, and can cause a wide range of adverse health effects, including cancer, respiratory infections, and asthma. The current Surgeon General’s Report concluded that there is no risk-free level of exposure to secondhand smoke. Even short exposures to secondhand smoke can cause blood platelets to become stickier, damage the lining of blood vessels, decrease coronary flow velocity reserves, and reduce heart rate variability, potentially increasing the risk of heart attack. New research indicates that private research conducted by cigarette company Philip Morris in the 1980s showed that secondhand smoke was highly toxic, yet the company suppressed the finding during the next two decades.[59]
Secondhand smoke is especially harmful to young children. It is responsible for between 150,000 and 300,000 lower respiratory tract infections in infants and children under 18 months of age, resulting in between 7,500 and 15,000 hospitalizations each year. It is associated with 430 sudden infant death syndrome (SIDS) deaths in the United States annually.[60]
Secondhand smoke causes the same negative health effects as tobacco smoking, particularly heart diseases and cancer. Nonsmokers who are exposed to secondhand smoke at home or work increase their heart disease risk by 25–30% and their lung cancer risk by 20–30%. Secondhand smoke has been estimated to cause 38,000 deaths per year, of which 3,400 are deaths from lung cancer in non-smokers.[61]
After a ban on smoking in all enclosed public places was introduced in Scotland in March 2006, there was a 17 percent reduction in hospital admissions for acute coronary syndrome. 67% of the decrease occurred in non-smokers.[62]
Carcinogens
Organic
There* The carcinogenity of tobacco smoke is not explained by nicotine per se, which is not carcinogenic or mutagenic. It can be a synergistic carcinogen, however, accelerating the growth of existing tumors.
Radioactive
In addition to chemical, nonradioactive carcinogens, tobacco and tobacco smoke contain small amounts of lead-210 (210Pb) and polonium-210 (210Po) both of which are radioactive carcinogens. Lead 210 is a product of the decay of radium-226 and, in turn, its decay product, radon-222; lead 210 then decays to bismuth-210 and then to polonium 210, emitting beta particles in both steps. Tarry particles containing these elements lodge in the smokers' lungs where airflow is disturbed; the concentration found where bronchioles bifurcate is 100 times higher than that in the lungs overall. This gives smokers much more intense exposure than would otherwise be encountered. Polonium 210, for instance, emits high energy alpha particles which, because of their large mass, are considered to be incapable of penetrating the skin more than 40 micrometres deep, but do considerable damage (estimated at 100 times as much chromosome damage as a corresponding amount of other radiation) when a process such as smoking causes them to be emitted within the body, where all their energy is absorbed by surrounding tissue. (Lead 210 also emits gamma rays).
The radioactive elements in tobacco are accumulated from the minerals in the soil, as with any plant, but are also captured on the sticky surface of the tobacco leaves in excess of what would be seen with plants not having this property. As might be expected, the radioactivity measured in tobacco varies widely depending on where and how it is grown. One study found that tobacco grown in India averaged only 0.09 pCi per gram of polonium-210, whereas tobacco grown in the United States averaged 0.516 pCi per gram. Another study of Indian tobacco, however, measured an average of 0.4 pCi of polonium 210 per cigarette, which also would be approximately a gram of tobacco. One factor in the difference between India and the United States may be the extensive use of apatite as fertilizer for tobacco in the United States, because it starves the plant for nitrogen, thereby producing more flavorful tobacco; apatite is known to contain radium, lead 210, and polonium 210. This would also account for increased concentration of these elements compared to other crops, which do not use this mineral as fertilizer.
The presence of polonium-210 in mainstream cigarette smoke has been experimentally measured at levels of 0.0263 - 0.036 pCi,[63] which is equivalent to about 0.1 pCi per milligram of smoke; or about 0.81 pCi of lead 210 per gram of dry condensed smoke. The amount of polonium 210 inhaled from a pack of 20 cigarettes is therefore about 0.72 pCi. This seems to be independent of any form of filtering or 'low tar' cigarette. This concentration results in a highly significant increase in the body burden of these compounds. Compared to nonsmokers, heavy smokers have four times greater radioisotope density throughout their lungs. The polonium 210 content of blood in smokers averages 1.72 pCi per kilogram, compared to 0.76 pCi per kilogram in nonsmokers. Higher concentrations of polonium 210 are also found in the livers of smokers than nonsmokers. Polonium 210 is also known to be incorporated into bone tissue, where the continued irradiation of bone marrow may be a cause of leukemia, although this has not been proved as yet.
Research by NCAR radiochemist Ed Martell determined that radioactive compounds in cigarette smoke are deposited in "hot spots" where bronchial tubes branch. Since tar from cigarette smoke is resistant to dissolving in lung fluid, the radioactive compounds have a great deal of time to undergo radioactive decay before being cleared by natural processes. Indoors, these radioactive compounds linger in secondhand smoke, and therefore greater exposure occurs when these radioactive compounds are inhaled during normal breathing, which is deeper and longer than when inhaling cigarettes. Damage to the protective epithelial tissue from smoking only increases the prolonged retention of insoluble polonium 210 compounds produced from burning tobacco. Martell estimated that a carcinogenic radiation dose of 80-100 rads is delivered the lung tissue of most smokers who die of lung cancer.[64]
In other experiments, the alpha particle dosage from polonium 210 received by smokers of two packs a day was measured at 82.5 millirads per day, which would total 752.5 rads per 25 years, 150 times higher than the approximately 5 rem received from natural background radiation over 25 years.[citation needed] Other estimates of the dosage absorbed over 25 years of heavy smoking range from 165 to 1,000 rem, all significantly higher than natural background. In the case of the less radioactive Indian tobacco referred to above, the dosage received from polonium 210 is about 24 millirads a day, totalling 219 rads over 25 years or still about 40 times the natural background radiation exposure. In fact, all these numbers of total body burden are misleadingly low, because the dosage rate in the immediate vicinity of the deposited polonium 210 in the lungs can be from 100 to 10,000 times greater than natural background radiation. Lung cancer is seen in laboratory animals exposed to approximately one fifth of this total dosage of polonium 210.
Whether the quantities of these elements are sufficient to cause cancer is still a matter of debate. Most studies of carcinogenicity of tobacco smoke involve painting tar condensed from smoke onto the skin of mice and monitoring for development of tumors of the skin, a relatively simple process. However, the specific properties of polonium 210 and lead 210 and the model for their action, as described above, do not permit such a simple assay and require more difficult studies, requiring dosage of the mice in a manner mimicking smoking behavior of humans and monitoring for lung cancer, more difficult to observe as it is internal to the mouse.
Some researchers suggest that the degree of carcinogenicity of these radioactive elements is sufficient to account for most, if not all, cases of lung cancer related to smoking. In support of this hypothetical link between radioactive elements in tobacco and cancer is the observation that bladder cancer incidence is also proportional to the amount of tobacco smoked, even though nonradioactive carcinogens have not been detected in the urine of even heavy smokers; however, urine of smokers contains about six times more polonium 210 than that of nonsmokers, suggesting strongly that the polonium 210 is the cause of the bladder carcinogenicity, and would be expected to act similarly in the lungs and other tissue. Furthermore, many of the lung cancers contracted by cigarette smokers are adenocarcinomas, which are characteristic of the type of damage produced by alpha particle radiation such as that of polonium 210. It has also been suggested that the radioactive and chemical carcinogens in tobacco smoke act synergistically to cause a higher incidence of cancer than each alone.
However, the view that polonium 210 is responsible for many cases of cancer in tobacco smokers is disputed by at least one researcher.[65][66]
Addiction
Nicotine
Nicotine that is contained in cigarettes or cigarette substitute (may or may not contain nicotine [67], e.g.: ruyan, etc) is a stimulant and is one of the main factors leading to continued tobacco smoking. Although the amount of nicotine inhaled with tobacco smoke is quite small (most of the substance is destroyed by the heat) it is still sufficient to cause physical[citation needed] and/or psychological[citation needed] dependence. The amount of nicotine absorbed by the body from smoking depends on many factors, including the type of tobacco, whether the smoke is inhaled, and whether a filter is used. Despite the design of various cigarettes advertised and even tested on machines to deliver less of the toxic tar, studies show that when smoked by humans instead of machines, they deliver the same net amount of smoke. Ingesting a compound by smoking is one of the most rapid and efficient methods of introducing it into the bloodstream, second only to injection, which allows for the rapid feedback which supports the smokers' ability to titrate their dosage. On average it takes about ten seconds for the substance to reach the brain. As a result of the efficiency of this delivery system, many smokers feel as though they are unable to cease. Of those who attempt cessation and last three months without succumbing to nicotine, most are able to remain smoke free for the rest of their lives.[19] There exists a possibility of depression in some who attempt cessation, as with other psychoactive substances. Depression is also common in teenage smokers; teens who smoke are four times as likely to develop depressive symptoms as their nonsmoking peers.[68]
Although nicotine does play a role in acute episodes of some diseases (including stroke, impotence, and heart disease) by its stimulation of adrenaline release, which raises blood pressure,[69] heart rate, and free fatty acids, the most serious longer term effects are more the result of the products of the smouldering combustion process. This has enabled development of various nicotine delivery systems, such as the nicotine patch or nicotine gum, that can satisfy the addictive craving by delivering nicotine without the harmful combustion by-products. This can help the heavily dependent smoker to quit gradually, while discontinuing further damage to health.
Genetic factors
According to three separate studies commissioned by governments in the US and Europe, scientists have identified a genetic link that makes people more likely to become addicted to tobacco. This genetic variation causes individuals to smoke more cigarettes, makes it harder for them to quit and increases their likelihood of developing lung cancer by up to 80%.[70]
Genetic markers of more than 35,000 people (mostly smokers and ex-smokers) were surveyed by scientists in three separate studies, and all three found lung cancer to be associated with similar sets of genetic differences. The genetic variations of note encode nicotine receptors on cells and were identified on a region of chromosome 15.[71] Possessing a single copy of the mutation raises an individual's risk of lung cancer by approximately 30%; for two copies the increase is about 80%. The gene was found to be attributable to 14% of lung cancer cases, and it was found to confer similar lung cancer risks irrespective of smoking status or quantity smoked.[72]
Epidemiology
A team of British scientists headed by Richard Doll carried out a longitudinal study of 34,439 medical specialists from 1951 to 2001, generally called the "British doctors study."[74] The study demonstrated that smoking decreased life expectancy by up to 10 years and that almost half of the smokers died from diseases possibly caused by smoking (cancer, heart disease, and stroke).
In the UK, the impact of smoking is felt most keenly by the lower social classes, which are known to have lower life expectancy than those in wealthier classes. Half the difference in survival to age 70 between social classes I and V is estimated to be due to the higher smoking prevalence in the lower class group.[75]
Beneficial effects
Tobacco has sometimes been reported to have isolated positive effects on certain medical conditions, presumably due to the biological effects of nicotine. Most notably, some studies have found that patients with Alzheimer's disease are more likely not to have smoked than the general population, which has been interpreted to suggest that smoking offers some protection against Alzheimer's. However, the research in this area is limited and the results are conflicting; some studies show that smoking increases the risk of Alzheimer's disease. A recent review of the available scientific literature concluded that the apparent decrease in Alzheimer risk may be simply due to the fact that smokers tend to die before reaching the age at which Alzheimer normally occurs. "Differential mortality is always likely to be a problem where there is a need to investigate the effects of smoking in a disorder with very low incidence rates before age 75 years, which is the case of Alzheimer's disease," it stated, noting that smokers are only half as likely as non-smokers to survive to the age of 80.[76]
Other findings include:
- Former and current smokers have a lower incidence of Parkinson's disease compared to people who have never smoked,[77][78] although the authors stated that it was more likely that the movement disorders which are part of Parkinson's disease prevented people from being able to smoke than that smoking itself was protective. Another study considered a possible role of nicotine in reducing Parkinson's risk: nicotine stimulates the dopaminergic system of the brain, which is damaged in Parkinson's disease, while other compounds in tobacco smoke inhibit MAO-B, an enzyme which produces oxidative radicals by breaking down dopamine.[79]
- A protective effect of current smoking against ulcerative colitis, although smoking increases the risk of Crohn's disease, the other form of inflammatory bowel disease.[80]
- Smoking reduces the risk of Kaposi's sarcoma in people without HIV infection.[81]
- There is some evidence for decreased rates of endometriosis in infertile smoking women,[82] although other studies have found that smoking increases the risk in infertile women.[83] There is little or no evidence of a protective effect in fertile women.
- Some preliminary data from 1996 suggested a reduced incidence of uterine fibroids,[84] but overall the evidence is unconvincing.[85]
- There is limited evidence that smoking reduces the incidence of pregnancy-induced hypertension,[86] but not when the pregnancy is with more than one baby (i.e. it has no effect on twins etc.).[87] Smoking does, however, increase the likelihood of almost every other pregnancy-related health risk to both mother and child, and is the single most preventable cause of illness and death among mothers and infants in the developed world.[88]
- A very large percentage of schizophrenics smoke tobacco as a form of self medication.[89][90][91][92] The high rate of tobacco use by the mentally ill is a major factor in their decreased life expectancy, which is about 25 years shorter than the general population.[93] Following the observation that smoking improves condition of people with schizophrenia, in particular working memory deficit, nicotine patches had been proposed as a way to treat schizophrenia.[94]
- Preliminary reports suggest that smoking can decrease the incidence of acne prophylactically. This was seen by a decreased percentage ratio of patients needing acne medication versus the percentage of entire population of smokers. (A smaller percentage of patients who smoked needed medication than found in the population as a whole).[95]
Incidental problems
An indirect public health problem posed by cigarettes is that of accidental fires, usually linked with consumption of alcohol. Numerous cigarette designs have been proposed, some by tobacco companies themselves, which would extinguish a cigarette left unattended for more than a minute or two, thereby reducing the risk of fire. Among American tobacco companies, some have resisted this idea, while others have embraced it. RJR Reynolds was a leader in making prototypes of these cigarettes in 1983[96]. and will make all of their U.S. market cigarettes to be fire-safe by 2010.[97] Phillip Morris is not in active support of it.[98] Lorillard, the nation's third largest tobacco company, seems to be ambivalent.[99]
See also
- List of additives in cigarettes
- Health issues related to smokeless tobacco
- Smoking cessation
- Vaporizer
References
- ^ WHO global burden of disease report 2008
- ^ WHO Report on the Global Tobacco Epidemic, 2008
- ^ "Nicotine: A Powerful Addiction." Centers for Disease Control and Prevention.
- ^ Cigarette Smoking Among Adults - United States, 2006
- ^ WHO/WPRO-Smoking Statistics
- ^ a b Ferrucci L, Izmirlian G, Leveille S; et al. (1999). "Smoking, physical activity, and active life expectancy". Am. J. Epidemiol. 149 (7): 645–53. PMID 10192312.
{{cite journal}}
: Explicit use of et al. in:|author=
(help)CS1 maint: multiple names: authors list (link) - ^ Doll R, Peto R, Boreham J, Sutherland I (2004). "Mortality in relation to smoking: 50 years' observations on male British doctors". BMJ. 328 (7455): 1519. doi:10.1136/bmj.38142.554479.AE. PMID 15213107.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Doll R, Peto R, Wheatley K, Gray R, Sutherland I (1994). "Mortality in relation to smoking: 40 years' observations on male British doctors". BMJ. 309 (6959): 901–11. PMID 7755693.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Centers for Disease Control. "Cigarette Smoking Among Adults - United States, 2006". Retrieved 2008-01-04.
- ^ Associated Press. "Tobacco expected to kill 1 billion this century". MSNBC. Retrieved 2008-01-04].
{{cite web}}
: Check date values in:|accessdate=
(help) - ^ Myers, David (2005), Exploring Psychology (6 ed.), Worth, p. 212, ISBN 0716786222
- ^ Witschi H (2001). "A short history of lung cancer". Toxicol. Sci. 64 (1): 4–6. PMID 11606795.
{{cite journal}}
: Unknown parameter|month=
ignored (help) - ^ Adler I. Primary malignant growths of the lungs and bronchi. New York: Longmans, Green, and Company; 1912., cited in Spiro SG, Silvestri GA (2005). "One hundred years of lung cancer". Am. J. Respir. Crit. Care Med. 172 (5): 523–9. doi:10.1164/rccm.200504-531OE. PMID 15961694.
{{cite journal}}
: Unknown parameter|month=
ignored (help) - ^ Villeneuve PJ, Mao Y (1994). "Lifetime probability of developing lung cancer, by smoking status, Canada". Canadian journal of public health. Revue canadienne de santé publique. 85 (6): 385–8. PMID 7895211.
- ^ "The Tobacco Reference Guide". Retrieved 2006-07-15.
- ^ Peate I (2005). "The effects of smoking on the reproductive health of men". Br J Nurs. 14 (7): 362–6. PMID 15924009.
- ^ Korenman SG (2004). "Epidemiology of erectile dysfunction". Endocrine. 23 (2–3): 87–91. doi:10.1385/ENDO:23:2-3:087. PMID 15146084.
- ^ Kendirci M, Nowfar S, Hellstrom WJ. (2005). "The impact of vascular risk factors on erectile function". Drugs Today (Barc). 41 (1): 65–74. doi:10.1358/dot.2005.41.1.875779. PMID 15753970.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ a b Quitting Smoking: Why To Quit and How To Get Help - National Cancer Institute
- ^ American Legacy Foundation factsheet on lung cancer; their cited source is: CDC (Centers for Disease Control) The Health Consequences of Smoking: A Report of the Surgeon General. 2004.
- ^ Lipworth L, Tarone RE, McLaughlin JK (2006). "The epidemiology of renal cell carcinoma". J. Urol. 176 (6 Pt 1): 2353–8. doi:10.1016/j.juro.2006.07.130. PMID 17085101.
{{cite journal}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^ Cui Y, Miller AB, Rohan TE (2006). "Cigarette smoking and breast cancer risk: update of a prospective cohort study". Breast Cancer Res. Treat. 100 (3): 293–9. doi:10.1007/s10549-006-9255-3. PMID 16773435.
{{cite journal}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^ Calle EE, Miracle-McMahill HL, Thun MJ, Heath CW (1994). "Cigarette smoking and risk of fatal breast cancer". Am. J. Epidemiol. 139 (10): 1001–7. PMID 8178779.
{{cite journal}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^ Iodice S, Gandini S, Maisonneuve P, Lowenfels AB (2008). "Tobacco and the risk of pancreatic cancer: a review and meta-analysis". Langenbecks Arch Surg. 393: 535. doi:10.1007/s00423-007-0266-2. PMID 18193270.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Kuper H, Boffetta P, Adami HO (2002). "Tobacco use and cancer causation: association by tumour type". J. Intern. Med. 252 (3): 206–24. PMID 12270001.
{{cite journal}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^ "Risk factors associated with age-related nuclear and cortical cataract : a case-control study in the Age-Related Eye Disease Study, AREDS Report No. 5". Ophthalmology. 108 (8): 1400–8. 2001. PMC 1473213. PMID 11470690.
Consistent findings have now been reported across many studies for gender, educational status, sunlight exposure, and smoking.
{{cite journal}}
: Unknown parameter|month=
ignored (help) - ^ Anstey KJ, von Sanden C, Salim A, O'Kearney R (2007). "Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies". Am. J. Epidemiol. 166 (4): 367–78. doi:10.1093/aje/kwm116. PMID 17573335.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Jacobsen LK, Krystal JH, Mencl WE, Westerveld M, Frost SJ, Pugh KR (2005). "Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers". Biol. Psychiatry. 57 (1): 56–66. doi:10.1016/j.biopsych.2004.10.022. PMID 15607301.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Brody AL, Mandelkern MA, Jarvik ME; et al. (2004). "Differences between smokers and nonsmokers in regional gray matter volumes and densities". Biol. Psychiatry. 55 (1): 77–84. PMID 14706428.
{{cite journal}}
: Explicit use of et al. in:|author=
(help); Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^ Akiyama H, Meyer JS, Mortel KF, Terayama Y, Thornby JI, Konno S (1997). "Normal human aging: factors contributing to cerebral atrophy". J. Neurol. Sci. 152 (1): 39–49. PMID 9395125.
{{cite journal}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^ Facchinetti et al. α,β-Unsaturated Aldehydes in Cigarette Smoke Release Inflammatory Mediators from Human Macrophages. American Journal of Respiratory Cell and Molecular Biology. Vol. 37, pp. 617-623, 2007. DOI: 10.1165/rcmb.2007-0130OC
- ^ "Health : Young smokers' heart attack risk". BBC. Retrieved 2005-12-18.
- ^ Con Stough, Gordon Mangan, Tim Bates, O. Pellett (1994) Smoking and Raven IQ. Psycho-pharmacology 116:382-384
- ^ a b Jarvis MJ (2004). "Why people smoke". BMJ. 328 (7434): 277–9. doi:10.1136/bmj.328.7434.277. PMC 324461. PMID 14751901.
{{cite journal}}
: Unknown parameter|month=
ignored (help) - ^ Hughes JR (2006). "Clinical significance of tobacco withdrawal". Nicotine Tob. Res. 8 (2): 153–6. doi:10.1080/14622200500494856. PMID 16766409.
{{cite journal}}
: Unknown parameter|month=
ignored (help) - ^ Sacco KA, Bannon KL, George TP (2004). "Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders". J. Psychopharmacol. (Oxford). 18 (4): 457–74. doi:10.1177/0269881104047273. PMC 1201375. PMID 15582913.
{{cite journal}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^ Kumari V, Postma P (2005). "Nicotine use in schizophrenia: the self medication hypotheses". Neurosci Biobehav Rev. 29 (6): 1021–34. doi:10.1016/j.neubiorev.2005.02.006. PMID 15964073.
- ^ Agarwal A, Prabakaran SA, Said TM (2005). "Prevention of oxidative stress injury to sperm". J. Androl. 26 (6): 654–60. doi:10.2164/jandrol.05016. PMID 16291955.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Robbins WA, Elashoff DA, Xun L; et al. (2005). "Effect of lifestyle exposures on sperm aneuploidy". Cytogenet. Genome Res. 111 (3–4): 371–7. doi:10.1159/000086914. PMID 16192719.
{{cite journal}}
: Explicit use of et al. in:|author=
(help)CS1 maint: multiple names: authors list (link) - ^ Emsley, John. Nature's Building Blocks. 2001. Oxford University Press.
- ^ Ness RB, Grisso JA, Hirschinger N; et al. (1999). "Cocaine and tobacco use and the risk of spontaneous abortion". N. Engl. J. Med. 340 (5): 333–9. PMID 9929522.
{{cite journal}}
: Explicit use of et al. in:|author=
(help); Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link)
Oncken C, Kranzler H, O'Malley P, Gendreau P, Campbell WA (2002). "The effect of cigarette smoking on fetal heart rate characteristics". Obstet Gynecol. 99 (5 Pt 1): 751–5. PMID 11978283.{{cite journal}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^ Venners SA, Wang X, Chen C; et al. (2004). "Paternal smoking and pregnancy loss: a prospective study using a biomarker of pregnancy". Am. J. Epidemiol. 159 (10): 993–1001. PMID 15128612.
{{cite journal}}
: Explicit use of et al. in:|author=
(help); Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^ The U.S. Surgeon General's Report (Chapter 5; pages 180-194).
- ^ "The Tobacco Reference Guide". Retrieved 2006-07-15.
- ^ Davies PDO, Yew WW, Ganguly D; et al. (2006). "Smoking and tuberculosis: the epidemiological association and pathogenesis". Trans R Soc Trop Med Hyg. 100: 291–8. doi:10.1016/j.trstmh.2005.06.034. PMID 16325875.
{{cite journal}}
: Explicit use of et al. in:|author=
(help)CS1 maint: multiple names: authors list (link) - ^ Jha P, Jacob B, Gajalakshmi V; et al. (2008). "A nationally representative case–control study of smoking and death in India". N Engl J Med. 358 (11): 1137–1147. doi:10.1056/NEJMsa0707719. PMID 18272886.
{{cite journal}}
: Explicit use of et al. in:|author=
(help)CS1 maint: multiple names: authors list (link) - ^ Nuorti JP, Butler JC, Farley MM; et al. (2000). "Cigarette smoking and invasive pneumococcal disease". N Engl J Med. 342: 681–9. PMID 10706897.
{{cite journal}}
: Explicit use of et al. in:|author=
(help)CS1 maint: multiple names: authors list (link) - ^ Arcavi L, Benowitz NL (2004). "Cigarette smoking and infection". 164: 2206–16. PMID 15534156.
{{cite journal}}
: Cite journal requires|journal=
(help) - ^ U.S. District Judge Gladys Kessler's Final Opinion, p.740
- ^ David M. Burns, M.D. (February 1998). "Cigars: Health Effects and Trends".
{{cite journal}}
: Cite journal requires|journal=
(help) - ^ Symm B, Morgan MV, Blackshear Y, Tinsley S (2005). "Cigar smoking: an ignored public health threat". J Prim Prev. 26 (4): 363–75. doi:10.1007/s10935-005-5389-z. PMID 15995804.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ a b c National Institutes of Health (1998-04-10). "Background on Cigar Monograph: Cigars: Health Effects and Trends". Retrieved 2008-01-04.
- ^ American Cancer Society. "Questions About Smoking, Tobacco, and Health". Retrieved 2008-01-04.
- ^ American Cancer Society. "Questions About Smoking, Tobacco, and Health". Retrieved 2008-01-04.
- ^ Henley SJ, Thun MJ, Chao A, Calle EE (2004). "Association between exclusive pipe smoking and mortality from cancer and other diseases". J. Natl. Cancer Inst. 96 (11): 853–61. PMID 15173269.
{{cite journal}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^ Loren Stein. "Pipe Smoking". A Healthy Me!. Retrieved 2008-01-04.
- ^ Commission on Life Sciences. "Environmental Tobacco Smoke: Measuring Exposures and Assessing Health Effects (1986)". Retrieved 2008-01-04.
- ^ Surgeon General of the United States. "Smoking and Health: A Report of the Surgeon General" (PDF). Retrieved 2008-07-25.
- ^ "Secondhand Smoke Fact Sheet", American Lung Association June 2007.
- ^ "Secondhand Smoke and Children Fact Sheet", American Lung Association June 2007.
- ^ "Tobacco-Free Florida", Centers for Disease Control & Prevention Fact Sheets
- ^ Pell JP, Haw S, Cobbe S; et al. (2008). "Smoke-free legislation and hospitalizations for acute coronary syndrome". N. Engl. J. Med. 359 (5): 482–91. doi:10.1056/NEJMsa0706740. PMID 18669427.
{{cite journal}}
: Explicit use of et al. in:|author=
(help); Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^ U.S. Army Center for Health Promotion and Preventive Medicine. "Radiological Sources of Potential Exposure and/or Contamination" (PDF).
- ^ E. A. Martell (1983). "Radiation Dose at Bronchial Bifurcations of Smokers from Indoor Exposure to Radon Progeny". Retrieved June 9.
{{cite web}}
: Check date values in:|accessdate=
and|year=
(help); Unknown parameter|accessyear=
ignored (|access-date=
suggested) (help)CS1 maint: year (link) - ^ Hecht, Stephen S. (1997). "Approaches to Chemoprevention of Lung Cancer Based on Carcinogens in Tobacco Smoke". Environmental Health Perspectives. 105 (S4). Retrieved 2006-12-06.
{{cite journal}}
: Unknown parameter|month=
ignored (help) - ^ Hecht, Stephen S. (July 21, 1999). "Tobacco Smoke Carcinogens and Lung Cancer". Journal of the National Cancer Institute. 91 (14): 1194–1210. doi:10.1093/jnci/91.14.1194. PMID 10413421. Retrieved 2006-12-06.
{{cite journal}}
: Check date values in:|date=
(help) - ^ http://en.wikipedia.org/wiki/Ruyan#Ruyan_Electronic_Cigarette.2C_Ruyan_E-Cigarette_.28Ruyan_V8.29
- ^ Smoking increases teen depression
- ^ Narkiewicz K, Kjeldsen SE, Hedner T (2005). "Is smoking a causative factor of hypertension?". Blood Press. 14 (2): 69–71. doi:10.1080/08037050510034202. PMID 16036482.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ [1]
- ^ Access : Genetic link for lung cancer identified : Nature News
- ^ Hung RJ, MacKay JD (2008). "A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25". Nature. 452 (7187): 633–7. PMID 18385738.
- ^ a b WHO Report on the Global Tobacco Epidemic, 2008
- ^ Richard Doll, Richard Peto, Jillian Boreham, Isabelle Sutherland (2004). "Mortality in relation to smoking: 50 years' observations on male British doctors". BMJ. 328 (1519): 1519. doi:10.1136/bmj.38142.554479.AE. PMID 15213107.
{{cite journal}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^ "Securing Good Health for the Whole Population". Retrieved 2006-11-13.
- ^ Osvaldo P. Almeida, Gary K. Hulse1, David Lawrence2 & Leon Flicker (2002). "Smoking as a risk factor for Alzheimer's disease: contrasting evidence from a systematic review of case-control and cohort studies". Addiction. 97: 15. doi:10.1046/j.1360-0443.2002.00016.x.
{{cite journal}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) CS1 maint: numeric names: authors list (link) - ^ Allam MF, Campbell MJ, Hofman A, Del Castillo AS, Fernández-Crehuet Navajas R (2004). "Smoking and Parkinson's disease: systematic review of prospective studies". Mov. Disord. 19 (6): 614–21. doi:10.1002/mds.20029. PMID 15197698.
{{cite journal}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^ Allam MF, Campbell MJ, Del Castillo AS, Fernández-Crehuet Navajas R (2004). "Parkinson's disease protects against smoking?". Behav Neurol. 15 (3–4): 65–71. PMID 15706049.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Quik, Maryka (2004-09). "Smoking, nicotine and Parkinson's disease". Trends in neurosciences. 27 (9): 561–8. doi:10.1016/j.tins.2004.06.008. ISSN 0166-2236. PMID 15331239.
{{cite journal}}
: Check date values in:|date=
(help) - ^ Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S (2006). "Smoking and inflammatory bowel disease: a meta-analysis". Mayo Clin. Proc. 81 (11): 1462–71. PMID 17120402.
{{cite journal}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^ Goedert JJ, Vitale F, Lauria C; et al. (2002). "Risk factors for classical Kaposi's sarcoma". J. Natl. Cancer Inst. 94 (22): 1712–8. PMID 12441327.
{{cite journal}}
: Explicit use of et al. in:|author=
(help); Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^ Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, Marshall LM, Hunter DJ (2004). "Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors". Am. J. Epidemiol. 160 (8): 784–96. doi:10.1093/aje/kwh275. PMID 15466501.
{{cite journal}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^ Calhaz-Jorge C, Mol BW, Nunes J, Costa AP (2004). "Clinical predictive factors for endometriosis in a Portuguese infertile population". Hum. Reprod. 19 (9): 2126–31. doi:10.1093/humrep/deh374. PMID 15229202.
{{cite journal}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^ Baron JA (1996). "Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spurious". Br. Med. Bull. 52 (1): 58–73. PMID 8746297.
{{cite journal}}
: Unknown parameter|month=
ignored (help) - ^ Schwartz SM, Marshall LM, Baird DD (2000). "Epidemiologic contributions to understanding the etiology of uterine leiomyomata". Environ. Health Perspect. 108 Suppl 5: 821–7. PMID 11035989.
{{cite journal}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^ Zhang J, Zeisler J, Hatch MC, Berkowitz G (1997). "Epidemiology of pregnancy-induced hypertension". Epidemiol Rev. 19 (2): 218–32. PMID 9494784.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Krotz S, Fajardo J, Ghandi S, Patel A, Keith LG (2002). "Hypertensive disease in twin pregnancies: a review". Twin Res. 5 (1): 8–14. PMID 11893276.
{{cite journal}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^ Maternal and Infant Health: Smoking During Pregnancy
- ^ McNeill, Ann (2001). "Smoking and mental health - a review of the literature" (PDF). SmokeFree London Programme. Retrieved 2008-10-05.
{{cite journal}}
: Cite journal requires|journal=
(help) - ^ Meltzer, H., Gill, B., Petticrew, M., Hinds. K. (1995). "OPCS Surveys of Psychiatric Morbidity Report 3: Economic Activity and Social Functioning of Adults With Psychiatric Disorders". London, Her Majesty’s Stationery Office.
{{cite journal}}
: Cite journal requires|journal=
(help)CS1 maint: multiple names: authors list (link) - ^ Kelly, Ciara (1999). "Smoking Habits, Current Symptoms, and Premorbid Characteristics of Schizophrenic Patients in Nithsdale, Scotland". The American Journal of Psychiatry. 156. American Psychiatric Association: 1751–7. PMID 10553739. Retrieved 2006-12-14.
{{cite journal}}
: Unknown parameter|coauthors=
ignored (|author=
suggested) (help) - ^ Hughes, J.R. (1986). "Prevalence of smoking among psychiatric outpatients". The American Journal of Psychiatry. 143. American Psychiatric Association: 993–7. PMID 3487983. Retrieved 2006-12-14.
{{cite journal}}
: Unknown parameter|coauthors=
ignored (|author=
suggested) (help) - ^ Schroeder SA (2007). "Shattuck Lecture. We can do better--improving the health of the American people". N. Engl. J. Med. 357 (12): 1221–8. doi:10.1056/NEJMsa073350. PMID 17881753.
- ^ Health Report - 22 July 2002 - Schizophrenia and Smoking
- ^ Alireza Firooz, Reza Sarhangnejad, Seyyed Massoud Davoudi, and Mansour Nassiri-Kashani (2005). "Acne and Smoking, Is There a relationship?". BMC Dermatology. 5: 2. doi:10.1186/1471-5945-5-2.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) CS1 maint: unflagged free DOI (link) - ^ NFPA :: Press Room :: News releases
- ^ http://www.nfpa.org/assets/files//FSC/ReynoldsLetter.pdf
- ^ Fire Safe Cigarettes :: Letter to tobacco companies
- ^ Fire Safe Cigarettes :: Letter to tobacco companies
Further reading
- "Smoking and health: physician responsibility. A statement of the Joint Committee on Smoking and Health. American College of Chest Physicians. American Thoracic Society. Asia Pacific Society of Respirology. Canadian Thoracic Society. European Respiratory Society, and International Union Against Tuberculosis and Lung Disease". Chest. 108 (4): 1118–21. 1995. PMID 7555125.
{{cite journal}}
: Unknown parameter|month=
ignored (help) - Boffetta P, Agudo A, Ahrens W; et al. (1998). "Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe". J. Natl. Cancer Inst. 90 (19): 1440–50. PMID 9776409.
{{cite journal}}
: Explicit use of et al. in:|author=
(help); Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link)